(S)-1-(DIPHENYLPHOSPHINO)-3,3-DIMETHYL-2-BUTYLAMINE, 95%, 100mg

(2-methoxy-1-methylethyl)(2-methylbenzyl)amine hydrochloride, 95.0%, 1g

1H-indene, 95.0%, 5g

(5-Bromo-3-(trifluoromethyl)pyridin-2-yl)methanol, 95.0%, 25mg

Ethyl 4-methylenecyclohexanecarboxylate, 95.0%, 250mg

4-Bromo-2,5-difluoronitrobenzene>98.0%(GC)5g

2,2'-Dibromo-1,1'-binaphthyl>96.0%(GC)1g

Monovanadate d'ammonium, min 99,8 %, pa, 250 g, emballage plastique.

1-Nitro-4-(2,2,2-trifluoroethoxy)benzene, 250mg

N-(4-hydroxyphenyl)-3-methylbutanamide, 95.0%, 1g

2-(4-Methylpiperazin-1-yl)phenylboronic acid, 97%, 10g

4-Methyl-1,2,5-oxadiazole-3-carboxylic acid, 97%, 5g

tert-Butyl 3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate, 95.0%, 1g